These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. Terasaki S; Nakanuma Y; Ogino H; Unoura M; Kobayashi K Am J Gastroenterol; 1991 Sep; 86(9):1194-9. PubMed ID: 1882800 [TBL] [Abstract][Full Text] [Related]
5. Cellular sensitivity to native type IV collagen in primary biliary cirrhosis. Suou T; Ago H; Sawada H; Hirayama C Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):275-91. PubMed ID: 8480075 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic hepatitis and primary biliary liver cirrhosis with D-penicillamine]. Mansurov KhKh; Mirodzhov GK; Ladnaia MM Klin Med (Mosk); 1981 Feb; 59(2):91-5. PubMed ID: 7289493 [No Abstract] [Full Text] [Related]
7. Open-label pilot study of tetracycline in the treatment of primary biliary cirrhosis. Maddala YK; Jorgensen RA; Angulo P; Lindor KD Am J Gastroenterol; 2004 Mar; 99(3):566-7. PubMed ID: 15056105 [No Abstract] [Full Text] [Related]
8. The late results of long-term treatment of primary biliary cirrhosis by corticosteroids. Howat HT; Ralston AJ; Varley H; Wilson JA Rev Int Hepatol; 1966; 16(2):227-38. PubMed ID: 5947845 [No Abstract] [Full Text] [Related]